These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31966907)

  • 1. Post-infantile giant cell hepatitis: A single center's experience over 25 years.
    Matta B; Cabello R; Rabinovitz M; Minervini M; Malik S
    World J Hepatol; 2019 Dec; 11(12):752-760. PubMed ID: 31966907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postinfantile Giant Cell Hepatitis in Native and Allograft Livers: A Multi-Institutional Clinicopathologic Study of 70 Cases.
    Jiao J; Chezar K; Zhang X; Wang D; Cao W; Bindu C; Chen W; Neto AG; Henn P; Riahi I; Wang HL; Papke DJ; Zhao L; Xue Y; Liao X; Zhang X
    Mod Pathol; 2023 Nov; 36(11):100298. PubMed ID: 37544363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postinfantile Giant Cell Hepatitis Secondary to Rheumatoid Arthritis.
    Martinez-Moad M; Wunderlich G; Diep D; Vasudevan A; Russell A; Janitz T; Aluri B; Oviedo A; Mysore Rangaraju A
    ACG Case Rep J; 2023 Apr; 10(4):e01006. PubMed ID: 37091202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic giant cell hepatitis: a subtype of post-infantile giant cell hepatitis?
    Zenda T; Araki I; Sasaki M
    Clin J Gastroenterol; 2019 Aug; 12(4):367-371. PubMed ID: 30767175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-infantile giant cell hepatitis.
    Thaler H
    Liver; 1982 Dec; 2(4):393-403. PubMed ID: 7167039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postinfantile Giant Cell Hepatitis with Features of Acute Severe Autoimmune Hepatitis Probably Triggered by Diclofenac in a Patient with Primary Myelofibrosis.
    Arvaniti P; Zachou K; Koukoulis GK; Dalekos GN
    Case Reports Hepatol; 2018; 2018():9793868. PubMed ID: 29713554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-infantile Giant Cell Hepatitis: A Literature Review and Meta-analysis.
    Jiao J; Zhang X
    J Clin Transl Pathol; 2022 Sep; 2(3):100-107. PubMed ID: 37092012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postinfantile giant cell hepatitis: an etiological and prognostic perspective.
    Bihari C; Rastogi A; Sarin SK
    Hepat Res Treat; 2013; 2013():601290. PubMed ID: 23555054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis.
    Protzer U; Dienes HP; Bianchi L; Lohse AW; Helmreich-Becker I; Gerken G; Meyer zum Büschenfelde KH
    Liver; 1996 Aug; 16(4):274-82. PubMed ID: 8878001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune post-infantile giant cell hepatitis: a case report and review of the literature.
    Xiao Y; Gao ZH; Deschenes M
    Can Liver J; 2021; 4(2):104-109. PubMed ID: 35991767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Old donors in liver transplantation for chronic hepatitis C].
    Aguilera V; Ponce M; Berenguer M; Moreno R; Rayón JM; Sanjuán F; Prieto M; Mir J
    Rev Esp Enferm Dig; 2007 Oct; 99(10):581-7. PubMed ID: 18052661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-infantile giant cell hepatitis: histological and immunohistochemical study.
    Johnson SJ; Mathew J; MacSween RN; Bennett MK; Burt AD
    J Clin Pathol; 1994 Nov; 47(11):1022-7. PubMed ID: 7829677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-liver transplant survival in hepatitis C patients is improving over time.
    O'Leary JG; Randall H; Onaca N; Jennings L; Klintmalm GB; Davis GL
    Liver Transpl; 2009 Apr; 15(4):360-8. PubMed ID: 19326409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation.
    Gibelli NE; Tannuri U; Mello ES; Cançado ER; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Pinho-Apezzato ML; Maksoud JG
    Pediatr Transplant; 2006 May; 10(3):371-6. PubMed ID: 16677364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
    Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
    Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
    Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
    Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation.
    Pappo O; Ramos H; Starzl TE; Fung JJ; Demetris AJ
    Am J Surg Pathol; 1995 Feb; 19(2):192-206. PubMed ID: 7832279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.
    Humar A; Crotteau S; Gruessner A; Kandaswamy R; Gruessner R; Payne W; Lake J
    Clin Transplant; 2007; 21(4):526-31. PubMed ID: 17645714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of idiopathic postinfantile giant cell hepatitis treated with a calcineurin inhibitor].
    Hof T; Flohr F; Thimme R; Kurz P; Thiel J
    Dtsch Med Wochenschr; 2021 Feb; 146(3):193-197. PubMed ID: 33513656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.